Achieve Life Sciences (ACHV) Revenue (2010 - 2016)
Achieve Life Sciences (ACHV) posted Revenue of $2.9 million for Q1 2016, down 51.2% on a QoQ basis from $6.0 million in Q4 2015, and up 113.97% year-over-year from $1.4 million in Q2 2015.
Achieve Life Sciences (ACHV) Revenue (2010 - 2016) Analysis & Trends
Achieve Life Sciences' Revenue history runs 7 years deep, the most recent figure standing at $2.9 million for Q1 2016.
- Quarterly Revenue rose 113.97% year-over-year to $2.9 million in Q1 2016, while the trailing twelve-month figure through Mar 2016 was $19.7 million (up 17.7% YoY) and the FY2015 annual result came in at $18.2 million, down 33.03% from the prior year.
- Revenue was $2.9 million for Q1 2016 at Achieve Life Sciences, down from $6.0 million in the prior quarter.
- Across five years, Revenue topped out at $11.7 million in Q1 2014 and bottomed at $1.3 million in Q1 2012.
- A 5-year average of $5.8 million and a median of $5.7 million in 2014 frame the typical range for Revenue.
- Annual changes were most pronounced in 2012 — Revenue surged 691.26% — and 2015, when it slumped 88.29%.
- Achieve Life Sciences' Revenue stood at $9.8 million in 2012, then retreated by 12.02% to $8.6 million in 2013, then sank by 34.3% to $5.7 million in 2014, then advanced by 6.56% to $6.0 million in 2015, then sank by 51.2% to $2.9 million in 2016.
- Business Quant data shows ACHV's Revenue at $2.9 million in Q1 2016, $6.0 million in Q4 2015, and $6.7 million in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Achieve Life Sciences | 2.54 Mn | 2.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 2.94 Mn |
| Dec 31, 2015 | 6.02 Mn |
| Sep 30, 2015 | 6.74 Mn |
| Jun 30, 2015 | 4.03 Mn |
| Mar 31, 2015 | 1.37 Mn |
| Dec 31, 2014 | 5.65 Mn |
| Sep 30, 2014 | 4.80 Mn |
| Jun 30, 2014 | 4.93 Mn |
| Mar 31, 2014 | 11.73 Mn |
| Dec 31, 2013 | 8.60 Mn |
| Sep 30, 2013 | 9.86 Mn |
| Jun 30, 2013 | 6.34 Mn |
| Mar 31, 2013 | 5.08 Mn |
| Dec 31, 2012 | 9.78 Mn |
| Sep 30, 2012 | 6.57 Mn |
| Jun 30, 2012 | 2.43 Mn |
| Mar 31, 2012 | 1.32 Mn |
| Dec 31, 2011 | 1.24 Mn |
| Sep 30, 2011 | 1.17 Mn |
| Jun 30, 2011 | 1.89 Mn |